Tag: Japan

Fiinovation (Innovative Financial Advisors Pvt Ltd) Nuclear Energy Safe and Cheap

Is nuclear energy safe is a question mostly asked by people of the developing nations and the answer to that is yes. Apart from small instances and the Fukushima incident in Japan there are no major mishaps that have occurred in the pursuit of nuclear energy for electricity generation which began soon after the discovery in the early 20th century that radioactive elements, such as radium, released immense amounts of energy, according to the principle of mass-energy equivalence. The Fukushima incident in Japan made mankind give a rethink on nuclear power and countries like Italy banned nuclear energy and Germany wants to close down all plants by 2022. Nuclear energy is much safer than other sources of energy especially when we compare with air pollution from coal, the largest supplier of electricity in India and the most dirtiest energy resource claims lives of more 1 lakh every year with almost 30 million people suffering from chronic bronchitis, chest discomforts and asthma attacks. However, nuclear energy which not only saves hydro and renewables but also doesn’t contribute to man-made climate change. >

Till today nuclear energy supplies are about 13% of global electricity and dozens of new reactors are being built in big economies like China, India and Russia. While US and much of the Developed world is in retreat with nuclear energy with new reactors not being developed or are in hold and the old ones are being retired. There is clear role of radioactivity and fear of nuclear accidents for the decline in demand of nuclear energy. The cost is even a bigger factor as the present nuclear reactors that produce inexpensive electricity get stalled due to billions of dollars going over budget in the construction if new plants forcing some utilities to abandon projects in midconstruction. Nuclear plants which have been made with designs from the cold war era actually become more expensive as they scale up. Larger plants require bigger and stronger containment domes that used expensive concrete and steel. Most of the plants outside France is not standardized which meant every reactor was produced made to order. In Fukushima meltdown no one was killed by the cost of accident was $100 billion and you have very expensive way to produce electricity. Cheap natural gas use in US and renewables preferred in much of Europe nuclear remain in decline in the first world countries until it gets cheaper.

However the question remains that can nuclear energy is cheap? Answer to that is yes it can be cheap after the development of entirely new reactor designs which can employ modular, mass-produced components with inherent safety characteristics that eliminate the need for the expensive backup systems that have helped inflate the costs of new plants in the past. Reactors with passive safety systems are likely to much cheaper as well as safer as there is no need to worry if power couldn’t be restored to the plant quickly in the event of disaster.

For more information visit: fiinovation

Athersys, Inc. (athx) – Financial And Strategic Swot Analysis Review

Aug, 2, 2014 : Company Profiles and Conferences presents a Company Report on “Athersys, Inc. (ATHX) – Financial and Strategic SWOT Analysis Review”, which helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Athersys, Inc. (ATHX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile is bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Athersys, Inc. (Athersys) is a biotechnology company. It carries out the discovery and development of therapeutic product candidates focused in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as cardiovascular diseases, inflammatory and immune disorders, neurological conditions and others. The company is also developing new drugs for treating obesity, cognition, attention and wakefulness.

Athersys, Inc. Key Recent Developments

May 08, 2014: Athersys Reports First Quarter 2014 Results
Mar 13, 2014: Athersys Reports Fourth Quarter and 2013 Annual Results
Jan 09, 2014: Athersys Announces New Patents in Japan for Stem Cell and Regenerative Medicine Technology
Nov 27, 2013: Athersys prices registered direct offering of common stock and warrants
Nov 25, 2013: Athersys to Present at 25th Annual Piper Jaffray Healthcare Conference